CD8A and AIDS: Serrano-Villar et al showed in the Madrid cohort that the CD4/CD8 ratio was significantly lower in patients suffering from non AIDS events compared to the other patients of the cohort, independently of CD4+ cells count and other prognostic factors, and this finding was consistent for all types of events including cardiovascular ones and end-stage kidney disease [21].